Vitrolife Financial Statements From 2010 to 2025
| VITR Stock | SEK 171.30 5.40 3.06% |
Check Vitrolife financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vitrolife's main balance sheet or income statement drivers, such as , as well as many indicators such as . Vitrolife financial statements analysis is a perfect complement when working with Vitrolife Valuation or Volatility modules.
Vitrolife |
Vitrolife AB Company Return On Equity Analysis
Vitrolife's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Vitrolife Return On Equity | 0.0246 |
Most of Vitrolife's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vitrolife AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Vitrolife AB has a Return On Equity of 0.0246. This is 100.1% lower than that of the Biotechnology sector and 100.07% lower than that of the Health Care industry. The return on equity for all Sweden stocks is 107.94% lower than that of the firm.
Vitrolife AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vitrolife's current stock value. Our valuation model uses many indicators to compare Vitrolife value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vitrolife competition to find correlations between indicators driving Vitrolife's intrinsic value. More Info.Vitrolife AB is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.83 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Vitrolife AB is roughly 1.20 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vitrolife's earnings, one of the primary drivers of an investment's value.About Vitrolife Financial Statements
Vitrolife shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Vitrolife investors may analyze each financial statement separately, they are all interrelated. The changes in Vitrolife's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vitrolife's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Vitrolife AB , a medical device company, develops, produces, and markets products for assisted reproduction. Vitrolife AB was founded in 1981 and is headquartered in Gothenburg, Sweden. Vitrolife operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 415 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vitrolife Stock Analysis
When running Vitrolife's price analysis, check to measure Vitrolife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitrolife is operating at the current time. Most of Vitrolife's value examination focuses on studying past and present price action to predict the probability of Vitrolife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitrolife's price. Additionally, you may evaluate how the addition of Vitrolife to your portfolios can decrease your overall portfolio volatility.